By Dani Kass ( November 2, 2016, 2:59 PM EDT) -- Valeant Pharmaceuticals International Inc. on Tuesday confirmed that it's looking to sell several of its assets, including gastrointestinal drugmaker Salix Pharmaceuticals Ltd., which it bought in 2015 for about $14.5 billion....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.